NO20025329L - Virulensgener, proteiner og deres anvendelse - Google Patents
Virulensgener, proteiner og deres anvendelseInfo
- Publication number
- NO20025329L NO20025329L NO20025329A NO20025329A NO20025329L NO 20025329 L NO20025329 L NO 20025329L NO 20025329 A NO20025329 A NO 20025329A NO 20025329 A NO20025329 A NO 20025329A NO 20025329 L NO20025329 L NO 20025329L
- Authority
- NO
- Norway
- Prior art keywords
- genes
- proteins
- virulence genes
- virulence
- products
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 230000001018 virulence Effects 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/36—Neisseria
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0011108.8A GB0011108D0 (en) | 2000-05-08 | 2000-05-08 | Virulence gene and protein and their use |
PCT/GB2001/002003 WO2001085772A2 (en) | 2000-05-08 | 2001-05-08 | Virulence genes, proteins, and their use |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20025329D0 NO20025329D0 (no) | 2002-11-06 |
NO20025329L true NO20025329L (no) | 2003-01-06 |
Family
ID=9891203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20025329A NO20025329L (no) | 2000-05-08 | 2002-11-06 | Virulensgener, proteiner og deres anvendelse |
Country Status (16)
Country | Link |
---|---|
US (2) | US20040087770A1 (no) |
EP (2) | EP1908839A3 (no) |
JP (1) | JP2003532404A (no) |
KR (3) | KR20030032948A (no) |
CN (2) | CN1840665A (no) |
AT (1) | ATE382056T1 (no) |
AU (1) | AU776508B2 (no) |
CA (1) | CA2408738A1 (no) |
CZ (1) | CZ20023642A3 (no) |
DE (1) | DE60132084T2 (no) |
GB (1) | GB0011108D0 (no) |
HU (1) | HUP0302481A2 (no) |
NO (1) | NO20025329L (no) |
NZ (3) | NZ522277A (no) |
RU (2) | RU2252224C2 (no) |
WO (1) | WO2001085772A2 (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996017951A2 (en) | 1994-12-09 | 1996-06-13 | Rpms Technology Limited | Identification of genes responsible for in vivo survival of microorganisms |
DK1108034T3 (da) | 1998-09-04 | 2008-11-10 | Emergent Product Dev Uk Ltd | Svækkede salmonella SPI2-mutanter som antigenbærere |
DK1163343T3 (da) | 1999-03-12 | 2010-04-19 | Glaxosmithkline Biolog Sa | Neisseria meningitidis antigene polypeptider, tilsvarende polynukleotider og beskyttende antistoffer |
GB9910812D0 (en) | 1999-05-10 | 1999-07-07 | Microscience Ltd | Vaccine composition |
EP2255826B1 (en) * | 2002-08-02 | 2016-04-13 | GlaxoSmithKline Biologicals S.A. | Neisserial vaccine compositions comprising a combination of antigens |
GB0330007D0 (en) * | 2003-12-23 | 2004-01-28 | Imp College Innovations Ltd | Vaccines |
CN101180079B (zh) | 2005-04-08 | 2012-07-18 | 惠氏公司 | 多价肺炎球菌多糖-蛋白质缀合物组合物 |
US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
EP2573080A1 (en) * | 2007-09-27 | 2013-03-27 | The United States of America, as Represented by the Secretary, Department of Health and Human Services | Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
US8703153B2 (en) | 2008-06-16 | 2014-04-22 | Prokarium Ltd. | Salmonella vectored vaccines against Chlamydia and methods of use |
GB0816447D0 (en) | 2008-09-08 | 2008-10-15 | Glaxosmithkline Biolog Sa | Vaccine |
JP2013522177A (ja) * | 2010-03-11 | 2013-06-13 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | グラム陰性細菌性、例えば髄膜炎菌性の感染または疾患に対する免疫原性組成物またはワクチン |
CN111118043B (zh) * | 2020-01-13 | 2022-07-05 | 吉林大学 | 一种苦豆子SaMET6基因克隆及其应用 |
CN116042562B (zh) * | 2022-03-11 | 2023-10-20 | 山东恒鲁生物科技有限公司 | 重组酵母菌及其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL98837A0 (en) * | 1990-07-19 | 1992-07-15 | Merck & Co Inc | Pharmaceutical compositions comprising proteins from the outer membrane of neisseria meningitidis and their use to increase the immune response |
US5338664A (en) * | 1992-12-04 | 1994-08-16 | American Cyanamid Company | Assay for detection of bacterial iron transport inhibitors |
US6121037A (en) * | 1994-10-18 | 2000-09-19 | Stojiljkovic; Igor | Bacterial hemoglobin receptor genes |
WO1996017951A2 (en) * | 1994-12-09 | 1996-06-13 | Rpms Technology Limited | Identification of genes responsible for in vivo survival of microorganisms |
FR2751000B1 (fr) * | 1996-07-12 | 1998-10-30 | Inst Nat Sante Rech Med | Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques |
WO1998017805A2 (en) * | 1996-10-24 | 1998-04-30 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, c/o Centers for Disease Control and Prevention, Technology Transfer Office | Invasion associated genes from neisseria meningitidis serogroup b |
GB9711964D0 (en) * | 1997-06-09 | 1997-08-06 | Medical Res Council | Live attenuated vaccines |
CN1204253C (zh) * | 1997-08-15 | 2005-06-01 | 乌得勒支大学 | 奈瑟氏球菌乳铁蛋白结合蛋白 |
CA2308606A1 (en) * | 1997-11-06 | 1999-05-20 | Chiron S.P.A. | Neisserial antigens |
AU3968599A (en) * | 1998-04-29 | 1999-11-16 | American Cyanamid Company | Vaccines containing recombinant pilin against Neisseria Gonorrhoeae or Neisseria Meningitidis |
GB9811260D0 (en) * | 1998-05-26 | 1998-07-22 | Smithkline Beecham Biolog | Novel compounds |
MXPA01003557A (es) * | 1998-10-09 | 2004-04-05 | Chiron Corp | Secuencias genomicas de neisseria y metodos para su uso. |
US6610836B1 (en) * | 1999-01-29 | 2003-08-26 | Genome Therapeutics Corporation | Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics |
AU780308B2 (en) * | 1999-04-30 | 2005-03-17 | J. Craig Venter Institute, Inc. | Neisseria genomic sequences and methods of their use |
-
2000
- 2000-05-08 GB GBGB0011108.8A patent/GB0011108D0/en not_active Ceased
-
2001
- 2001-05-08 AT AT01925742T patent/ATE382056T1/de not_active IP Right Cessation
- 2001-05-08 DE DE60132084T patent/DE60132084T2/de not_active Expired - Fee Related
- 2001-05-08 CZ CZ20023642A patent/CZ20023642A3/cs unknown
- 2001-05-08 RU RU2002132891/13A patent/RU2252224C2/ru not_active IP Right Cessation
- 2001-05-08 JP JP2001582371A patent/JP2003532404A/ja active Pending
- 2001-05-08 EP EP07114502A patent/EP1908839A3/en not_active Withdrawn
- 2001-05-08 US US10/275,026 patent/US20040087770A1/en not_active Abandoned
- 2001-05-08 NZ NZ522277A patent/NZ522277A/en unknown
- 2001-05-08 EP EP01925742A patent/EP1287024B1/en not_active Expired - Lifetime
- 2001-05-08 AU AU52422/01A patent/AU776508B2/en not_active Ceased
- 2001-05-08 KR KR1020027014876A patent/KR20030032948A/ko not_active Application Discontinuation
- 2001-05-08 CN CNA2005101362903A patent/CN1840665A/zh active Pending
- 2001-05-08 NZ NZ532297A patent/NZ532297A/en unknown
- 2001-05-08 HU HU0302481A patent/HUP0302481A2/hu unknown
- 2001-05-08 CA CA002408738A patent/CA2408738A1/en not_active Abandoned
- 2001-05-08 CN CN01809191A patent/CN1427892A/zh active Pending
- 2001-05-08 NZ NZ549068A patent/NZ549068A/en unknown
- 2001-05-08 WO PCT/GB2001/002003 patent/WO2001085772A2/en active IP Right Grant
-
2002
- 2002-11-06 NO NO20025329A patent/NO20025329L/no not_active Application Discontinuation
-
2005
- 2005-01-24 RU RU2005101623/13A patent/RU2005101623A/ru not_active Application Discontinuation
-
2007
- 2007-08-17 US US11/893,649 patent/US20080241151A1/en not_active Abandoned
- 2007-08-29 KR KR1020070087191A patent/KR20070102447A/ko not_active Application Discontinuation
-
2008
- 2008-07-10 KR KR1020080067099A patent/KR20080080069A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ522277A (en) | 2004-05-28 |
CZ20023642A3 (cs) | 2003-04-16 |
RU2252224C2 (ru) | 2005-05-20 |
HUP0302481A2 (hu) | 2003-10-28 |
EP1287024B1 (en) | 2007-12-26 |
KR20080080069A (ko) | 2008-09-02 |
GB0011108D0 (en) | 2000-06-28 |
CA2408738A1 (en) | 2001-11-15 |
AU776508B2 (en) | 2004-09-09 |
CN1427892A (zh) | 2003-07-02 |
DE60132084T2 (de) | 2008-12-11 |
DE60132084D1 (de) | 2008-02-07 |
EP1908839A3 (en) | 2008-07-16 |
WO2001085772A2 (en) | 2001-11-15 |
ATE382056T1 (de) | 2008-01-15 |
RU2005101623A (ru) | 2006-07-10 |
EP1908839A2 (en) | 2008-04-09 |
AU5242201A (en) | 2001-11-20 |
JP2003532404A (ja) | 2003-11-05 |
EP1287024A2 (en) | 2003-03-05 |
US20080241151A1 (en) | 2008-10-02 |
NZ532297A (en) | 2005-07-29 |
KR20030032948A (ko) | 2003-04-26 |
CN1840665A (zh) | 2006-10-04 |
US20040087770A1 (en) | 2004-05-06 |
NZ549068A (en) | 2008-03-28 |
NO20025329D0 (no) | 2002-11-06 |
WO2001085772A3 (en) | 2002-03-28 |
KR20070102447A (ko) | 2007-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20025329L (no) | Virulensgener, proteiner og deres anvendelse | |
IS6895A (is) | Aðferð til að bera kennsl á, einangra og vinna mótefnavaka við ákveðnum sjúkdómsvaldi | |
DE69932717D1 (de) | Methoden und produkte zur induzierung mukosaler immunität | |
CY1107950T1 (el) | Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι | |
DE69926729D1 (de) | Transgenes kaninchen, dass ein funktionelles menschliches lipoprotein(a) exprimiert | |
NO20032111L (no) | Nye medikamentblandinger basert pa tiotropium-salter og pa salmeterol-salter | |
NO20050063L (no) | 2-heteroaryl karboksamider | |
NZ515936A (en) | Antigenic Neisserial peptides | |
GB0121998D0 (en) | Attenuated bacteria useful in vaccines | |
NO20023006L (no) | Virulens gener, proteiner og deres anvendelse | |
DK1471936T3 (da) | HIV-Vaccine og fremgangsmåde til anvendelse | |
DE60011560D1 (de) | Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert | |
NO20062469L (no) | Streptococcus phocae vaksine | |
NO20013102D0 (no) | Gener, proteiner og deres anvendelse | |
DE602005025202D1 (de) | Subtilasevarianten mit veränderter immunogenität | |
DE60126765D1 (de) | Virulenz gene, proteine, und ihre verwendung | |
DE60142786D1 (de) | Zusammensetzungen und methoden zur behandlung von candidosen | |
WO2002016612A3 (en) | Genes and proteins, and their uses | |
DK1074266T3 (da) | Levende svækkede bakterier til anvendelse i vaccine | |
DK1763515T3 (da) | 4-Triflourmethoxyphenoxybenzen-4'-sulfonsyrer, fremgangsmåde til deres fremstilling og anvendelse i lægemidler | |
DK1313850T3 (da) | Nucleinsyre og tilsvarende protein med navnet 85PB3 anvendelige til behandling og påvisning af cancer | |
DK1423429T3 (da) | Antistoffer mod caspase-8 og deres fremstilling og anvendelse | |
WO2001057075A3 (en) | Virulence genes, proteins, and their use | |
DE60024977D1 (de) | Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen | |
BR0308180A (pt) | protéinas de superfìcie de leptospira |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |